Literature DB >> 9673425

Comparison of haemodynamic responses to cilnidipine and nicardipine in an experimental model of acute congestive heart failure.

K Noguchi1, T Matsuzaki, T Koyama, T Itomine, M Sakanashi.   

Abstract

1. The haemodynamic effects of cilnidipine, a new calcium channel blocker, were examined in a canine model of acute congestive heart failure and were compared with those of nicardipine at equihypotensive doses. 2. The model was prepared by injections of saponin into coronary arteries of anaesthetized open-chest dogs followed by volume loading and continuous i.v. infusion of methoxamine. After the treatment, aortic blood flow (AoF) and left ventricular dP/dt markedly decreased, while left ventricular end-diastolic pressure (LVEDP), right atrial pressure and systemic vascular resistance (SVR) increased. Cilnidipine (0.3, 1.0 and 3.0 micrograms/kg per min), nicardipine (0.3, 1.0 and 3.0 micrograms/kg per min) or the respective vehicle was given i.v. after accomplishment of heart failure. 3. These drugs both produced a comparable reduction in aortic pressure and an increase in AoF associated with profound decreases in LVEDP, SVR and coronary vascular resistance. In contrast, administration of nicardipine was associated with significant increases in heart rate and cardiac contractility but that of cilnidipine was not. 4. These results indicate that cilnidipine as well as nicardipine can exert beneficial haemodynamic effects in a model of acute heart failure probably through lessening afterload and cilnidipine may moderate reflex-induced sympathetic stimulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673425     DOI: 10.1111/j.1440-1681.1998.tb02248.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  2 in total

1.  Comparison of anti-anginal effect of cilnidipine with those of nicardipine and nifedipine in the vasopressin-induced angina model of rats.

Authors:  Xin Cao; Yuji Nakamura; Takeshi Wada; Hiroko Izumi-Nakaseko; Kentaro Ando; Bingmei Zhu; Bin Xu; Akira Takahara; Masaki Saitoh; Atsushi Sugiyama
Journal:  Heart Vessels       Date:  2016-05-18       Impact factor: 2.037

2.  A two-for-one bargain: using cilnidipine to treat hypertension and its comorbidities.

Authors:  Rugmani Padmanabhan Iyer; Merry L Lindsey; Robert J Chilton
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-29       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.